• [email protected]
  • +971 507 888 742
Submit Manuscript
SciAlert
  • Home
  • Journals
  • Information
    • For Authors
    • For Referees
    • For Librarian
    • For Societies
  • Contact
  1. Journal of Pharmacology and Toxicology
  2. Vol 6 (4), 2011
  3. 427-432
  • Online First
  • Current Issue
  • Previous Issues
  • More Information
    Aims and Scope Editorial Board Guide to Authors Article Processing Charges
    Submit a Manuscript

Journal of Pharmacology and Toxicology

Year: 2011 | Volume: 6 | Issue: 4 | Page No.: 427-432
DOI: 10.3923/jpt.2011.427.432

Facebook Twitter Digg Reddit Linkedin StumbleUpon E-mail

Article Trend



Total views 362

Search


Authors


H. Sheth

Country: India

D.K. Suresh

Country: India

R. Hasan

Country: India

Md S. Khalid

Country: India

S. Mahesh

Country: India

Keywords


  • drug interaction
  • streptozotocin (STZ)
  • nateglinide
  • antidiabetic effect of pioglitazone
  • Influence of bosentan
Research Article

Influence of Bosentan on Antidiabetic Effect of Pioglitazone and Nateglinide in Experimental Animals

H. Sheth, D.K. Suresh, R. Hasan, Md S. Khalid and S. Mahesh
The present study was carried out to evaluate the drug-drug interaction between antidiabetic drugs and antihypertensive drug. Interaction of Pioglitazone, the known Thiazolidinedione antidiabetic drug and Nateglinide, the known Meglitinide class antidiabetic drug with Bosentan, an antihypertensive drug was evaluated in healthy and Streptozotocin (STZ) induced diabetic rats. The blood samples were collected from rats at different time interval upto 24 h and blood glucose was estimated. Bosentan (10 mg kg-1, p.o.) pretreatment has not significantly altered the onset of antidiabetic effect of Pioglitazone (0.3 mg kg-1, p.o.) but significantly decreased the peak antidiabetic effect in healthy and Streptozotocin induced diabetic rats (44.74±2.56% reduction before treatment to 34.59±0.25% reduction after treatment), while duration of antidiabetic effect was reduced from 16 h to less than 12 h in both groups. Similarly pretreatment with Bosentan (10 mg kg-1, p.o.) has significantly no effect on the onset of antidiabetic effect of Nateglinide (50 mg kg-1, p.o.) but it significantly reduced the peak antidiabetic effect in healthy and Streptozotocin induced diabetic rats (46.15±1.25% reduction before treatment to 37.57±1.61% reduction after treatment), while duration of antidiabetic effect was reduced from 12 h to less than 8 h in both groups. This study indicates that Therapeutic Drug Monitoring (TDM) has to be required to readjust the therapeutic doses of Bosentan and antidiabetic drugs like Pioglitazone and Nateglinide when they used concomitantly.
PDF Fulltext XML References Citation

How to cite this article

H. Sheth, D.K. Suresh, R. Hasan, Md S. Khalid and S. Mahesh, 2011. Influence of Bosentan on Antidiabetic Effect of Pioglitazone and Nateglinide in Experimental Animals. Journal of Pharmacology and Toxicology, 6: 427-432.

DOI: 10.3923/jpt.2011.427.432

URL: https://scialert.net/abstract/?doi=jpt.2011.427.432

Related Articles

Incidence of Diabetic Nephropathy in Southern Nigeria
Pharmacodynamic Drug Interaction of Metformin with Statins in Rats
Vaccines for Hypertension Disorder: Beneficial or Detrimental

Leave a Comment


Your email address will not be published. Required fields are marked *

Useful Links

  • Journals
  • For Authors
  • For Referees
  • For Librarian
  • For Socities

Contact Us

Office Number 1128,
Tamani Arts Building,
Business Bay,
Deira, Dubai, UAE

Phone: +971 507 888 742
Email: [email protected]

About Science Alert

Science Alert is a technology platform and service provider for scholarly publishers, helping them to publish and distribute their content online. We provide a range of services, including hosting, design, and digital marketing, as well as analytics and other tools to help publishers understand their audience and optimize their content. Science Alert works with a wide variety of publishers, including academic societies, universities, and commercial publishers.

Follow Us
© Copyright Science Alert. All Rights Reserved